Cargando…

Human Wharton’s jelly-derived mesenchymal stromal cells promote bone formation in immunodeficient mice when administered into a bone microenvironment

BACKGROUND: Wharton’s Jelly (WJ) Mesenchymal Stromal Cells (MSC) have emerged as an attractive allogeneic therapy for a number of indications, except for bone-related conditions requiring new tissue formation. This may be explained by the apparent recalcitrance of MSC,WJ to differentiate into the os...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cabrera-Pérez, Raquel, Ràfols-Mitjans, Alexis, Roig-Molina, Ángela, Beltramone, Silvia, Vives, Joaquim, Batlle-Morera, Laura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10638709/ https://www.ncbi.nlm.nih.gov/pubmed/37950242 http://dx.doi.org/10.1186/s12967-023-04672-9

Ejemplares similares

Osteogenic commitment of Wharton’s jelly mesenchymal stromal cells: mechanisms and implications for bioprocess development and clinical application
por: Cabrera-Pérez, Raquel, et al.
Publicado: (2019)

Bone Marrow and Wharton’s Jelly Mesenchymal Stromal Cells are Ineffective for Myocardial Repair in an Immunodeficient Rat Model of Chronic Ischemic Cardiomyopathy
por: Tang, Xian-Liang, et al.
Publicado: (2023)

Wharton’s Jelly Mesenchymal Stromal Cells and Derived Extracellular Vesicles as Post-Myocardial Infarction Therapeutic Toolkit: An Experienced View
por: Muñoz-Domínguez, Noelia, et al.
Publicado: (2021)

The Treasury of Wharton's Jelly
por: Guenther, Rebecca, et al.
Publicado: (2021)

Effects of maternal obesity on Wharton’s Jelly mesenchymal stromal cells
por: Badraiq, Heba, et al.
Publicado: (2017)

The Immunomodulatory Potential of Wharton's Jelly Mesenchymal Stem/Stromal Cells
por: Vieira Paladino, Fernanda, et al.
Publicado: (2019)

Wharton’ jelly mesenchymal stromal cell therapy for ischemic brain injury
por: Wu, Kuo-Jen, et al.
Publicado: (2018)

Transplantation of human bone marrow mesenchymal stromal cells reduces liver fibrosis more effectively than Wharton’s jelly mesenchymal stromal cells
por: Rengasamy, Mathiyazhagan, et al.
Publicado: (2017)

Interaction between Macrophages and Human Mesenchymal Stromal Cells Derived from Bone Marrow and Wharton’s Jelly—A Comparative Study
por: Dymowska, Marta, et al.
Publicado: (2021)

Concise Review: Wharton's Jelly: The Rich, but Enigmatic, Source of Mesenchymal Stromal Cells
por: Davies, John E., et al.
Publicado: (2017)

Compliance with Good Manufacturing Practice in the Assessment of Immunomodulation Potential of Clinical Grade Multipotent Mesenchymal Stromal Cells Derived from Wharton’s Jelly
por: Grau-Vorster, Marta, et al.
Publicado: (2019)

Preclinical Development of a Therapy for Chronic Traumatic Spinal Cord Injury in Rats Using Human Wharton’s Jelly Mesenchymal Stromal Cells: Proof of Concept and Regulatory Compliance
por: Vives, Joaquim, et al.
Publicado: (2022)

3D in-vitro cultures of human bone marrow and Wharton’s jelly derived mesenchymal stromal cells show high chondrogenic potential
por: Lamparelli, Erwin Pavel, et al.
Publicado: (2022)

Characterization of Bone Marrow and Wharton’s Jelly Mesenchymal Stromal Cells Response on Multilayer Braided Silk and Silk/PLCL Scaffolds for Ligament Tissue Engineering
por: Liu, Xing, et al.
Publicado: (2020)

Osteogenic Induction of Wharton's Jelly-Derived Mesenchymal Stem Cell for Bone Regeneration: A Systematic Review
por: Ansari, Ayu Suraya, et al.
Publicado: (2018)

Bone marrow vs Wharton’s jelly mesenchymal stem cells in experimental sepsis: a comparative study
por: Laroye, Caroline, et al.
Publicado: (2019)

Mesenchymal stromal cells derived from whole human umbilical cord exhibit similar properties to those derived from Wharton's jelly and bone marrow
por: Mennan, Claire, et al.
Publicado: (2016)

Protein synthesis and secretion in human mesenchymal cells derived from bone marrow, adipose tissue and Wharton’s jelly
por: Amable, Paola Romina, et al.
Publicado: (2014)

Comparisons of Differentiation Potential in Human Mesenchymal Stem Cells from Wharton's Jelly, Bone Marrow, and Pancreatic Tissues
por: Kao, Shih-Yi, et al.
Publicado: (2015)

Comparative Proteomic Analysis of the Mesenchymal Stem Cells Secretome from Adipose, Bone Marrow, Placenta and Wharton’s Jelly
por: Shin, Sungho, et al.
Publicado: (2021)

Wharton’s jelly absence: a possible cause of stillbirth
por: Damasceno, Eduarda Bittencourt, et al.
Publicado: (2013)

Antibacterial and Immunomodulatory Properties of Acellular Wharton’s Jelly Matrix
por: Dubus, Marie, et al.
Publicado: (2022)

Wharton’s jelly‐derived stromal cells and their cell therapy applications in allogeneic haematopoietic stem cell transplantation
por: Pochon, Cécile, et al.
Publicado: (2022)

Characterization of Osteogenesis and Chondrogenesis of Human Decellularized Allogeneic Bone with Mesenchymal Stem Cells Derived from Bone Marrow, Adipose Tissue, and Wharton’s Jelly
por: Chen, Cheng-Fong, et al.
Publicado: (2021)

Mesenchymal Stem/Stromal Cell Production Compliant with Good Manufacturing Practice: Comparison between Bone Marrow, the Gold Standard Adult Source, and Wharton’s Jelly, an Extraembryonic Source
por: Laroye, Caroline, et al.
Publicado: (2019)

Comparative Analyses of Immunosuppressive Characteristics of Bone-Marrow, Wharton’s Jelly, and Adipose Tissue-Derived Human Mesenchymal Stem Cells
por: Karaöz, Erdal, et al.
Publicado: (2017)

The challenge of developing human 3D organoids into medicines
por: Vives, Joaquim, et al.
Publicado: (2020)

Evaluation of HLA-G Expression in Multipotent Mesenchymal Stromal Cells Derived from Vitrified Wharton’s Jelly Tissue
por: Mallis, Panagiotis, et al.
Publicado: (2018)

Neuroprotective Action of Human Wharton’s Jelly-Derived Mesenchymal Stromal Cell Transplants in a Rodent Model of Stroke
por: Wu, Kuo-Jen, et al.
Publicado: (2018)

Efficient Non-Viral Gene Modification of Mesenchymal Stromal Cells from Umbilical Cord Wharton’s Jelly with Polyethylenimine
por: Ramos-Murillo, Ana Isabel, et al.
Publicado: (2020)

Biofabrication of a Tubular Model of Human Urothelial Mucosa Using Human Wharton Jelly Mesenchymal Stromal Cells
por: Garzón, Ingrid, et al.
Publicado: (2021)

Evaluation of the Optimal Manufacturing Protocols and Therapeutic Properties of Mesenchymal Stem/Stromal Cells Derived from Wharton’s Jelly
por: Sypecka, Monika, et al.
Publicado: (2022)

AFM-based Analysis of Wharton’s Jelly Mesenchymal Stem Cells
por: Szydlak, Renata, et al.
Publicado: (2019)

Umbilical cord-derived Wharton’s jelly for regenerative medicine applications
por: Gupta, Ashim, et al.
Publicado: (2020)

Decellularization of Wharton’s Jelly Increases Its Bioactivity and Antibacterial Properties
por: Dubus, M., et al.
Publicado: (2022)

Intranasal delivery of human umbilical cord Wharton's jelly mesenchymal stromal cells restores lung alveolarization and vascularization in experimental bronchopulmonary dysplasia
por: Moreira, Alvaro, et al.
Publicado: (2019)

Increased Proliferation and Analysis of Differential Gene Expression in Human Wharton's Jelly-derived Mesenchymal Stromal Cells under Hypoxia
por: Nekanti, Usha, et al.
Publicado: (2010)

Identifying Biomarkers of Wharton’s Jelly Mesenchymal Stromal Cells Using a Dynamic Metabolic Model: The Cell Passage Effect
por: Laflaquière, Benoît, et al.
Publicado: (2018)

The Effect of Wharton Jelly-Derived Mesenchymal Stromal Cells and Their Conditioned Media in the Treatment of a Rat Spinal Cord Injury
por: Chudickova, Milada, et al.
Publicado: (2019)

Xeno-Free Human Wharton’s Jelly Mesenchymal Stromal Cells Maintain Their Characteristic Properties after Long-Term Cryopreservation
por: Mathen, Caroline, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ik63cvadqv6gvbhne46gastf0d